Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:52:02.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T13:50:02.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new phase II open-label study of nivolumab combined with ipilimumab and bicalutamide for HER2-negative metastatic or unresectable breast cancer, with changes in the study's collaborators and revision number. The previous goal of the protocol has been removed, indicating a shift in focus.
    Difference
    50%
    Check dated 2025-04-16T01:46:08.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, indicating a new release. Additionally, a date has been added, which may signify an important upcoming event or deadline.
    Difference
    0.2%
    Check dated 2025-04-08T20:22:29.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The webpage has updated its date-related content, removing several past dates and adding new future dates, indicating a shift in the timeline of events or availability.
    Difference
    0.8%
    Check dated 2025-03-10T23:48:19.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-03-03T22:12:09.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.